Search Results - "Servigna, Mercedes"

Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: A multicentric, double-blind, placebo-controlled trial by Baptista, Trino, Rangel, Nairy, Fernández, Virginia, Carrizo, Edgardo, El Fakih, Yamily, Uzcátegui, Euderruh, Galeazzi, Tatiana, Gutiérrez, María A, Servigna, Mercedes, Dávila, Adriana, Uzcátegui, Marycelvia, Serrano, Ana, Connell, Lisette, Beaulieu, Serge, de Baptista, Enma Araujo

“…Abstract Background Excessive body weight gain (BWG) is a clinically relevant side effect of olanzapine administration. The primary objective of this study was…”
Get full text

Colonic transit diagnostic test shows significant gastrointestinal hypomotility in clozapine-treated patients in comparison with subjects treated with other antipsychotics by Baptista, Trino, Carrizo, Edgardo, Fernandez, Erika, Connell, Lisette, Servigna, Mercedes, Parra, Agner, Quintero, Jesus, Pabón, Albis, Sandia, Ignacio, Uzcáteguid, Euderruh, Serrano, Ana, Pirela, Natacha, Villarreal, Lisbeth

“…Abstract Background Constipation occurs in 25–60% of the subjects during administration of the antipsychotic drug (AP) clozapine (CLZ). Methods We used a…”
Get full text

Safety of long-term clozapine administration. Frequency of cardiomyopathy and hyponatraemia: Two cross-sectional, naturalistic studies by Serrano, Ana, Rangel, Nairy, Carrizo, Edgardo, Uzcátegui, Euderruh, Sandia, Ignacio, Zabala, Angélica, Fernández, Erika, Tálamo, Eduardo, Servigna, Mercedes, Prieto, Dexi, Connell, Lisette, Baptista, Trino

“…Background: The antipsychotic drug (APD) clozapine (CLZ) is under-prescribed because of concerns about its safety. We evaluated in separate protocols the…”
Get full text